Cartesian Therapeutics | News, Hiring, Layoffs, Competitors, CEO, Fundraising Insights

Cartesian Therapeutics is a clinical-stage biotechnology company focused on pioneering mRNA cell therapies for the treatment of autoimmune...


Cartesian Therapeutics LinkedIn profile Cartesian Therapeutics X profile Cartesian Therapeutics Crunchbase profile
Cartesian Therapeutics logo

Cartesian Therapeutics is a clinical-stage biotechnology company focused on pioneering mRNA cell therapies for the treatment of autoimmune diseases. The company is developing innovative therapies, including its lead asset Descartes-08, which is in Phase 2b clinical development for generalized myasthenia gravis and Phase 2 for systemic lupus erythematosus. Cartesian's mission is to extend the potential of cell therapy to patients with autoimmune conditions.

Website
Headquarters
Frederick, Maryland
Size
51-200 employees
Industry
Biotechnology Research
Specialities
Immunotherapy, Oncology, Molecular Biology, Immunology, Myasthenia Gravis, ARDS, Cell Therapy, NETs, Gene Therapy, Cancer Research, multiple myeloma, SLE, mRNA, CAR-T, Systemic lupus erythematosus, Autoimmunity, Autoimmune Disease, Lupus

🛍️ Cartesian Therapeutics Product and Pricing News →

👔 Cartesian Therapeutics CEO, Management and Leadership Team →

⚔️ Cartesian Therapeutics Alternatives and Competitors →

💼 Cartesian Therapeutics Hiring and Layoffs →

🤖 Cartesian Therapeutics Developer, Integration and Automation News →

📈 Cartesian Therapeutics Financials, Fundraising and Valuation News →

Monitor your competitors, key accounts, or your own company with RivalSense AI

🛍️ Cartesian Therapeutics Product and Pricing News


👔 Cartesian Therapeutics CEO, Management and Leadership Team


⚔️ Cartesian Therapeutics Alternatives and Competitors

  • Minerva Biotechnologies
  • |
  • Asc Therapeutics
  • |
  • ImStem Biotechnology
  • |
  • Miltenyi Biomedicine
  • |
  • Amgen
  • |
  • Bristol Myers Squibb
  • |
  • Chugai Pharma USA, Inc.
  • |
  • Werewolf Therapeutics
  • |
  • Vor Biopharma
  • |
  • Tmunity Therapeutics
  • |
  • IM Therapeutics
  • |
  • Intensity Therapeutics
  • |
  • Vitruvian Biomedical
  • |
  • Collaborative Medicinal Development
  • |
  • AnTolRx
  • |
  • Novartis
  • |
  • Gilead Sciences
  • |
  • Regeneron
  • |
  • Zymeworks Inc.
  • |
  • Sangamo Therapeutics, Inc.
  • |
  • bluebird bio
  • |
  • Immunocore
  • |
  • Travere Therapeutics
  • |
  • Indivior
  • |
  • Edgewise Therapeutics
  • |
  • Ocular

Monitor your competitors, key accounts, or your own company with RivalSense AI


💼 Cartesian Therapeutics Hiring and Layoffs

  • On April 29, 2025, Cartesian Therapeutics announced that their Chief Technology Officer, Dr. Metin Kurtoglu, will transition to a consultant role from May 1, 2025, to April 30, 2026.
  • Cartesian Therapeutics is currently seeking a Head of Clinical Safety and Development in the United States.


🤖 Cartesian Therapeutics Developer, Integration and Automation News


📈 Cartesian Therapeutics Financials, Fundraising and Valuation News


People also viewed